Special Issue on Drug Design, Development and Therapy

Drug design is a brilliant process of developing new drugs based on biological targets. It involves designing molecules that are similar in shape and charge to biomolecular targets in order to bind to them. The goal of this special issue is to provide a platform for scientists and academicians all over the world to promote, share, and discuss various new issues and developments in the area of Drug Design, Development and Therapy.

In this special issue, we intend to invite front-line researchers and authors to submit original research and review articles on exploring Drug Design, Development and Therapy. Potential topics include, but are not limited to:

• Drug target identification and validation
• Gene therapy, cell therapy and immunotherapy
• Clinical drug evaluation
• Biochemical analyses of drug targets and their pathways
• Drug analysis and drug discovery
• Distribution, pharmacokinetics and metabolic transformations of drugs
• Covid-19 drugs
• Drug abuse
• Drug stability
• OTC drugs and supplements
• Cardiovascular drugs
• Pharmacotherapy
• Therapeutic drug monitoring

Authors should read over the journal’s For Authors carefully before submission. Prospective authors should submit an electronic copy of their complete manuscript through the journal’s Paper Submission System.

Please kindly specify the “Special Issue” under your manuscript title. The research field “Special Issue - Drug Design, Development and Therapy” should be selected during your submission.

Special Issue Timetable:

Guest Editor:

For further questions or inquiries, please contact Editorial Assistant at

jbm@scirp.org.